SELLAS Life Sciences (SLS) Shares Outstanding (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Shares Outstanding for 7 consecutive years, with $20.6 million as the latest value for Q3 2022.
- On a quarterly basis, Shares Outstanding rose 29.7% to $20.6 million in Q3 2022 year-over-year; TTM through Sep 2022 was $20.6 million, a 29.7% increase, with the full-year FY2021 number at $15.9 million, up 11.51% from a year prior.
- Shares Outstanding was $20.6 million for Q3 2022 at SELLAS Life Sciences, roughly flat from $20.6 million in the prior quarter.
- In the past five years, Shares Outstanding ranged from a high of $24.2 million in Q1 2019 to a low of $2.0 million in Q2 2019.
- A 4-year average of $13.4 million and a median of $15.5 million in 2021 define the central range for Shares Outstanding.
- Peak YoY movement for Shares Outstanding: soared 235.44% in 2020, then increased 5.44% in 2022.
- SELLAS Life Sciences' Shares Outstanding stood at $5.1 million in 2019, then soared by 180.6% to $14.3 million in 2020, then increased by 11.51% to $15.9 million in 2021, then increased by 29.52% to $20.6 million in 2022.
- Per Business Quant, the three most recent readings for SLS's Shares Outstanding are $20.6 million (Q3 2022), $20.6 million (Q2 2022), and $15.9 million (Q1 2022).